Opiant Pharmaceuticals

About:

Opiant Pharmaceuticals is a pharmaceutical company that develops treatments for drug overdose and addictions.

Top Investors: Biomedical Advanced Research and Development Authority (BARDA), Pontifax

Description:

Opiant Pharmaceuticals is a pharmaceutical company that develops treatments for drug overdose and addictions leveraging intranasal and injectable delivery technologies. The company, formerly known as Lightlake Therapeutics, was founded in 2009, has a team of addiction experts, and is headquartered in Santa Monica, California.

Total Funding Amount:

$52M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Santa Monica, California, United States

Founded Date:

2009-03-02

Contact Email:

info(AT)opiant.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-01-25

IPO Status:

Private

Industries: